Results 61 to 70 of about 22,097 (178)

Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy

Journal of High Institute of Public Health, 2013
Background: Children in remission from acute lymphoblastic leukemia (ALL) have a high prevalence of immune system defects; one of them is the decrease of vaccine-induced antibody seropositivity rates.
Heba S. Selim, Soraya A. El shazly, Mostafa A. Salama, Reham H. Abdolmonem   +3 more
doaj   +1 more source

The efficacy of 20% salicylic acid solution versus intralesional MMR vaccine combination with 20% salicylic acid solution in treatment of plane wart

Advanced Medical Journal
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori, Ali Mozan Dhahir Elethawi   +1 more
doaj   +1 more source

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Indian Journal of Community Medicine, 2010
Background: Rubella vaccination is not yet included in National Immunization Schedule in India. Serosurvey is frequently used to assess epidemiologic pattern of Rubella in a community.
Sharma Hitt, Chowdhari Sunil, Raina Tilak, Bhardwaj Subodh, Namjoshi Gajanan, Parekh Sameer   +5 more
doaj  

Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination Programs

Vaccines
Background: Childhood cancer survivors (CCSs) often experience impaired humoral immunity because of cancer treatments that increase their susceptibility to vaccine-preventable diseases. This study aimed to assess the seroprevalence of tetanus and rubella
Alexander Zadruzny, Eva Tiselius, Tiia Lepp, Teodora Aktas, Teghesti Tecleab, Samuel Hellman, Maja Jahnmatz, Anna Nilsson   +7 more
doaj   +1 more source

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India

International Journal of Noncommunicable Diseases, 2018
Vaccines are essential to ensure that the population is immune to certain diseases, and immunization is one of the most cost-effective interventions to prevent the occurrence of the diseases.
Madhu Gupta, Kanica Kaushal, Nikita Sharma, Atul Gupta, Abu Mohammad Bashar, Suresh Dalpath, Shivani Gupta, G B Singh   +7 more
doaj   +1 more source

Rubella Vaccination [PDF]

Archives of Pediatrics & Adolescent Medicine, 1979
S R, Preblud, P I, Nieburg, A D, Brandling-Bennett, A R, Hinman, K L, Herrmann   +4 more
openaire   +4 more sources

On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000–2023, Namibia

Vaccines
Introduction: The WHO Measles and Rubella Strategic Framework 2021–2030 within the Immunization Agenda 2030 includes both measles and rubella elimination goals and provides guidance to countries for planning and implementing the measles and rubella ...
Balcha G. Masresha, Messeret E. Shibeshi, Roselina de Wee, Nicholas Shapumba, Takudzwa Sayi, Susan E. Reef, James L. Goodson   +6 more
doaj   +1 more source

Accelerating Global Measles and Rubella Eradication—Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic

Vaccines
No vaccine has been more effective in reducing disease burden, especially in preventing child deaths, than measles-containing vaccine. The return on investment makes measles-containing vaccine one of the most cost-effective public health measures ...
David N. Durrheim, Jon K. Andrus, Shahina Tabassum, David Githanga, Mira Kojouharova, Nadia Talab   +5 more
doaj   +1 more source

Genetic associations with mumps and rubella antibody response after MMR vaccination in 6- and 15-month-old children

Vaccine: X
Background: Measles, mumps, and rubella (MMR) vaccines have significantly improved public health worldwide. However, variation in vaccine response among immunized individuals poses a threat to both individual protection and herd immunity.
Jesper Kiehn Sørensen, Dorthe Maria Vittrup, Andreas Jensen, Michelle Malon, Anne Cathrine Zimakoff, Sejun Kim, Jonas Bybjerg-Grauholm, Simranjeet Kaur, Flemming Pociot, Lone Graff Stensballe, Jannet Svensson   +10 more
doaj   +1 more source

Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings. [PDF]

Healthcare (Basel), 2023
Ferrari C, Somma G, Gentili S, Manili G, Mauro G, Treglia M, Trabucco Aurilio M, Magrini A, Coppeta L.   +8 more
europepmc   +1 more source